VectorY

0 followers


VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for large disease areas of high unmet medical need. By combining state-of-the-art technologies and novel and scientific concepts, VectorY’s mission is to bring innovative therapies... Read more

Industries

Employees

11-50

Links

Org chart

Sander Van Deventer
Chief Executive Officer

Sander Van Deventer

Collapse
Elena Ritsou
Chief Corporate Officer
Barbara Sanders
VP, Vector Development
Femke Hoeksema
Director PD
Raygene Martier, PhD
Intellectual Property Manager
Rob Haselberg
Patient Partnership [interim]
Claus Sundgreen
Consultant Medical Director
Wouter Pos
Director of Antibody Technology
Sandra Lemmens
HR Manager A.i
Michael Wyzga
Chief Financial Officer